John Darby

John Darby is a seasoned biophysicist specializing in enzymology, protein design, and drug discovery. Currently serving as a Principal Scientist at Xyme, Darby previously held the role of Senior Biophysical Drug Discovery Scientist at Exscientia, where they contributed to drug discovery projects through surface plasmon resonance data analysis. Darby earned a PhD from the Institute of Cancer Research, having explored protein-protein interactions and their potential as drug targets. Their extensive experience includes postdoctoral research at leading institutions, focusing on fragment-based ligand discovery and therapeutic inhibition of endonuclease enzymes.